You are viewing: India Single Cell Analysis Market analysis
Part of: Single Cell Analysis Market (Global)

The India Single Cell Analysis Market was valued at $71 Million in 2025 and projected to reach to $169.2 Million by 2030, representing a compound annual growth rate of 19.0%. India's single cell analysis market is poised for exceptional growth, driven by strengthening genomics research capabilities and increasing healthcare sector modernization.

India Single Cell Analysis Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 19.0%, significantly outpacing global market expansion.
  • India's advancement in genomics research, increasing investment in biotechnology infrastructure, and rising adoption of precision medicine are driving this accelerated growth trajectory. The Indian single cell analysis market is benefiting from growing research collaborations, government initiatives supporting life sciences, and expanding pharmaceutical and diagnostic sectors.
  • India's position as a global hub for contract research organizations (CROs) and emerging biotech companies is catalyzing demand for advanced analytical technologies.
  • Between 2025 and 2030, India is expected to capture increasing market share within the Asia Pacific region, supported by cost-competitive solutions and skilled scientific workforce. Key applications in India include cancer research, immunology, and stem cell biology, with academic institutions and private research centers driving adoption.
  • India's regulatory environment and growing clinical research infrastructure position the country as a critical growth market for single cell analysis technologies through 2030..

Key Market Statistics

  • CAGR (2025-2030) 19.0% CAGR
  • Market Size, 2025 ~USD 71 Million
  • Forecast, 2030 ~USD 169.2 Million
  • Country India

India Single Cell Analysis Market Overview

Fastest Growing Market in Asia :

India's single cell analysis market is expanding at 19% CAGR, significantly outpacing the global growth rate of 14.7%, positioning it as one of the most dynamic markets in the region.

Genomics Research Expansion :

India's advancement in genomics research infrastructure and government initiatives like the National Institute of Biomedical Genomics are driving adoption of single cell analysis technologies across research institutions.

Precision Medicine Adoption :

Rising adoption of precision medicine in Indian healthcare systems, coupled with increasing awareness among clinicians and researchers, is accelerating demand for single cell analysis solutions.

Biotechnology Investment Surge :

Substantial increases in biotechnology infrastructure investment and funding from both government and private sectors are enabling Indian laboratories to adopt advanced single cell analysis platforms.

India Single Cell Analysis Market Dynamics

  • The market's 19% CAGR reflects India's emergence as a biotechnology hub with growing research collaborations and institutional investments in advanced analytical technologies. The forecast expansion from $71.0 million in 2025 to $169.2 million by 2030 underscores India's commitment to precision medicine and personalized healthcare.
  • Continued government support, rising pharmaceutical R&D activities, and expanding academic research programs will sustain this momentum, making India a critical market for single cell analysis solution providers..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • India's single cell analysis market is valued at $71.0 million in 2025 and is forecast to reach $169.2 million by 2030, representing a 19.0% CAGR.
      • India's growth rate significantly exceeds the global average, positioning the country as a high-growth market within Asia Pacific for single cell analysis technologies.
      • Government support for biotechnology, expanding CRO sector, and rising precision medicine adoption are primary catalysts driving India's market expansion.
      • Academic institutions and private research centers in India are increasingly adopting single cell analysis for cancer, immunology, and stem cell research applications.

      Single Cell Analysis Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ACADEMIC & RESEARCH LABORATORIES (End User)
      Forecast Period 2025–2030
      Growth Rate CAGR of 14.7% from 2025 to 2030
      Largest Segment CONSUMABLES (Product)
      Market Size Base Year (Billions) ~USD 3.81 (2025)
      Revenue Forecast (Billions) ~USD 7.56 (2030)
      Segments Covered Application, Type, Cell Type, End User, Product

      India Single Cell Analysis Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Application

      • Medical Applications
      • Research Applications

      By Type

      • Assay Kits
      • Beads
      • Cancer Research
      • Circulating Tumor Cells
      • Immunology Research
      • In Vitro Fertilization
      • Microplates
      • Neurology Research
      • Non-Invasive Prenatal Diagnosis
      • Other Consumables
      • Other Research Applications
      • Reagents
      • Stem Cell Research

      By Cell Type

      • Animal Cells
      • Human Cells
      • Microbial Cells

      By End User

      • Academic & Research Laboratories
      • Biotechnology & Pharmaceutical Companies
      • Cell Banks & Ivf Centers
      • Hospitals & Diagnostic Laboratories

      By Product

      • Consumables
      • Instruments

      Target Audience

      • Biotechnology Companies : Biotech firms need India-specific market data to assess market entry opportunities, competitive dynamics, and revenue potential in the rapidly growing single cell analysis segment.
      • Research Institutions & Universities : Academic and research organizations require market insights to justify infrastructure investments, secure funding for genomics research programs, and understand technology adoption trends in India.
      • Healthcare & Diagnostic Providers : Hospital networks and diagnostic centers need market intelligence to evaluate single cell analysis integration into precision medicine offerings and understand patient demand in India.
      • Investors & Venture Capitalists : Investment firms require comprehensive India market analysis to identify high-growth opportunities, assess portfolio companies' market positioning, and make strategic funding decisions in biotech.
      • Government & Policy Makers : Healthcare policymakers and government agencies need market data to inform biotechnology policy, allocate research funding, and develop strategies supporting India's genomics research ecosystem.

      Key Companies in the India Single Cell Analysis Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing and packaging),Pharmaceutical development services,Drug substance services (API and biologics),
      ABCAM PLCUnited KingdomPrivate CompanyPrimary antibodies,Secondary and conjugated antibodies,Immunoassays (singleplex) and kits,
      BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics (chemistry, hematology, immunoassay, urinalysis, blood banking, hemostasis, integrated systems),Life science research and discovery (flow cytometry, genomic and protein analysis, liquid handling, research automation),Industrial and particle characterization (coulter counters, particle size, zeta potential, electrochemistry),
      DECODE GENETICSIcelandPrivate CompanyInternal genomics support for Amgen R&D,External research collaborations and consortia,Genome sequencing and analytical services,
      BDUnited StatesPublic CompanyMedical Essentials (syringes, needles, IV catheters, sharps, basic disposables),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems and related services),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, media, filtration, aseptic fill-finish),Life Sciences (instruments, genomics, proteomics, imaging, lab automation),Diagnostics (clinical instruments, consumables, software, services),
      10X GENOMICSUnited StatesPublic CompanyChromium instruments,Chromium consumables & QuantumScale kits,Visium spatial platform (instruments, slides, reagents),
      MERCK KGAAGermanyPublic CompanyLife Science (tools, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, gases, equipment),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      QIAGENNetherlandsPublic CompanySample technology consumables and instruments,PCR and digital PCR (research and clinical),Molecular diagnostics assays (TB, oncology, SRH, transplant, viral load),
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based instruments and consumables,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Instruments and Systems,Life Science Reagents and Consumables,
      DIASORIN S.P.A.ItalyPublic CompanyLIAISON XL / LIAISON XS immunodiagnostics,Molecular diagnostics (Simplexa, LIAISON PLEX assays),xMAP technology and other IVD solutions,
      STANDARD BIOTOOLSUnited StatesPublic CompanyProteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and legacy genomics),Services, software, and other,
      SARTORIUS AGGermanyPublic CompanyBioprocess solutions (bioreactors, filtration, chromatography, fluid management),Lab products and services (weighing, pipetting, filtration, water systems, microbiological testing),Analytical solutions (BLI, cytometry, live-cell imaging, SPR, PAT and data analytics),
      CORNING INCORPORATEDUnited StatesPublic CompanyOptical communications (fiber, cable, connectivity, hardware),Display glass substrates (LCD and OLED),Specialty materials and mobile consumer electronics glass,
      CYTEK BIOSCIENCESUnited StatesPublic CompanyAurora / Aurora Evo / Aurora CS spectral systems,Northern Lights and mid-range flow cytometers,Amnis imaging flow cytometers,

      PATHEON INC

      Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees specializing in life science research products.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees manufacturing laboratory instruments and diagnostics.

      DECODE GENETICS

      Decode Genetics is an Iceland-based private company founded in 1996 with 331 employees focused on genetic research and analysis.

      BD

      BD is a United States-based public company founded in 1897 with 72,000 employees manufacturing medical devices, diagnostics, and life science tools.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees providing laboratory equipment, reagents, and services.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees operating diversified businesses including life sciences and diagnostics.

      10X GENOMICS

      10X Genomics is a United States-based public company founded in 2012 with 1,178 employees developing single-cell and spatial genomics solutions.

      MERCK KGAA

      Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating in pharmaceuticals, life sciences, and performance materials.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees manufacturing analytical instruments and life science tools.

      QIAGEN

      QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and sample preparation solutions.

      ILLUMINA, INC.

      Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees developing DNA sequencing and genetic analysis technologies.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees manufacturing life science research and clinical diagnostics products.

      DIASORIN S.P.A.

      DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees specializing in in vitro diagnostics and immunoassay systems.

      STANDARD BIOTOOLS

      Standard Biotools is a United States-based public company founded in 1999 with 387 employees developing microfluidics and single-cell analysis platforms.

      SARTORIUS AG

      Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees providing laboratory and bioprocess equipment and services.

      CORNING INCORPORATED

      Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass, ceramics, and life science products.

      CYTEK BIOSCIENCES

      Cytek Biosciences is a United States-based public company founded in 1992 with 678 employees developing flow cytometry and cell analysis technologies.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Quantified market data for India showing $71M (2025) to $169.2M (2030) growth validates investment decisions and helps stakeholders understand the market's expansion trajectory and revenue opportunities.
      • Competitive Positioning Strategy : Detailed India-specific insights enable companies to benchmark against regional competitors, identify market gaps, and develop targeted go-to-market strategies for the Indian single cell analysis sector.
      • Investment & Funding Decisions : Comprehensive market analysis supports venture capitalists, private equity firms, and corporate investors in evaluating India's biotechnology sector potential and making informed funding allocation decisions.
      • Product Development Roadmap : India-focused market intelligence guides R&D teams in developing solutions aligned with local research needs, regulatory requirements, and healthcare infrastructure capabilities specific to the Indian market.
      • Partnership & Expansion Planning : Actionable market data helps identify partnership opportunities, distribution channels, and expansion strategies tailored to India's unique genomics research ecosystem and healthcare landscape.

      Frequently asked questions

      What is the current market size of single cell analysis in India?

      India's single cell analysis market is valued at $71.0 million in 2025 and is projected to grow to $169.2 million by 2030.

      What is the expected growth rate for India's single cell analysis market?

      India's single cell analysis market is expected to grow at a compound annual growth rate (CAGR) of 19.0% from 2025 to 2030.

      What are the primary drivers of growth in India's single cell analysis market?

      Key growth drivers in India include government biotechnology initiatives, expansion of the CRO sector, increasing precision medicine adoption, and growing research collaborations in academic and private institutions.

      Which applications are driving demand for single cell analysis in India?

      Primary applications in India include cancer research, immunology studies, and stem cell biology, with adoption concentrated in academic institutions and private research centers.

      How does India's single cell analysis market growth compare to global trends?

      India's 19.0% CAGR significantly outpaces the global market CAGR of 14.7%, making India one of the fastest-growing markets for single cell analysis technologies.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-cell analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), and Society for Laboratory Automation and Screening (SLAS), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the global single-cell analysis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks, and IVF centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      The following is a breakdown of the primary respondents:

      Single Cell Analysis Market
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Bottom-up Approach

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the single-cell analysis business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Top-down Approach

      • After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

      Single Cell Analysis Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Single-cell analysis is a method for examining individual cells across various parameters, particularly beneficial when dealing with diverse cell populations. This approach focuses on studying a single cell isolated from tissues in a multicellular organism. Technologies including flow cytometry and microfluidics are used for single-cell analysis purpose. Such analysis facilitates the exploration of variations between cells within a population. Currently, single-cell analysis finds extensive applications in cancer research, immunology, stem cell research, and neurobiology.

      Stakeholders

      • Single-cell analysis product manufacturers, vendors, and distributors
      • Academic and research laboratories
      • Pharmaceutical and biopharmaceutical companies
      • Venture capitalists and investors
      • Government organizations
      • Private research firms
      • Cell Banks & IVF centers
      • Hospitals & diagnostic centers

      Report Objectives

      • To define, describe, segment, and forecast the single-cell analysis market by product, cell type, technique, application, end user, and region
      • To provide detailed information about the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
      • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-cell analysis market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
      • To strategically profile the key players in the global single-cell analysis market and comprehensively analyze their core competencies2 and market rankings
      • To track and analyze competitive developments in the single-cell analysis market, such as product launches, acquisitions, collaborations, expansions, and partnerships
      • To benchmark players within the single-cell analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business excellence and product strategy

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
      Company Information
      • Detailed analysis and profiling of additional market players (up to five).
      Geographical Analysis
      • A further breakdown of the Rest of Europe  single-cell analysis market into countries
      • A further breakdown of the Rest of Asia Pacific single-cell analysis market into countries
      • A further breakdown of the Rest of Latin American single-cell analysis market into countries
      • A further breakdown of the Rest of Middle East single-cell analysis market into countries

      Get the Full Single Cell Analysis Market Report

      Full forecast, segment splits, and company analysis for all Single Cell Analysis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status